Clinical Trial Update: Busulfan in Multiple Myeloma [Phase 1]

View source ↗

Summary

The Phase 1 clinical trial of busulfan in multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: Guido Tricot | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED